About this Journal Submit a Manuscript Table of Contents
Infectious Diseases in Obstetrics and Gynecology
Volume 2011 (2011), Article ID 942937, 9 pages
http://dx.doi.org/10.1155/2011/942937
Review Article

Screening for Cytomegalovirus during Pregnancy

Medical College of Virginia Campus, Virginia Commonwealth University, P.O. Box 980163, Richmond, VA 23298-0163, USA

Received 31 January 2011; Revised 31 March 2011; Accepted 25 May 2011

Academic Editor: Grace John-Stewart

Copyright © 2011 Stuart P. Adler. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Kenneson and M. J. Cannon, “Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection,” Reviews in Medical Virology, vol. 17, no. 4, pp. 253–276, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. F. A. Colugnati, S. A. Staras, S. C. Dollard, and M. J. Cannon, “Incidence of cytomegalovirus infection among the general population and pregnant women in the United States,” BMC Infectious Diseases, vol. 7, article 71, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. K. B. Fowler, S. Stagno, R. F. Pass, W. J. Britt, T. J. Boll, and C. A. Alford, “The outcome of congenital cytomegalovirus infection in relation to maternal antibody status,” The New England Journal of Medicine, vol. 326, no. 10, pp. 663–667, 1992. View at Scopus
  4. K. Stratton, J. Durch, and R. Lawrence, Vaccines for the 21st Century: A Tool for Decisionmaking, National Academy Press, Washington, DC, USA, 2001.
  5. C. C. Morton and W. E. Nance, “Newborn hearing screening—a silent revolution,” The New England Journal of Medicine, vol. 354, no. 20, pp. 2151–2164, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. J. Jeon, M. Victor, S. P. Adler, et al., “Knowledge and awareness of congenital cytomegalovirus among women,” Infectious Diseases in Obstetrics and Gynecology, vol. 2006, Article ID 80383, 7 pages, 2006. View at Publisher · View at Google Scholar · View at PubMed
  7. G. Rahav, “Congenital cytomegalovirus infection—a question of screening,” Israel Medical Association Journal, vol. 9, no. 5, pp. 392–394, 2007. View at Scopus
  8. M. Forsgren, “Prevention of congenital and perinatal infections,” Euro Surveillance, vol. 14, no. 9, pp. 2–4, 2009. View at Scopus
  9. M. Bodéus, B. Kabamba-Mukadi, F. Zech, C. Hubinont, P. Bernard, and P. Goubau, “Human cytomegalovirus in utero transmission: follow-up of 524 maternal seroconversions,” Journal of Clinical Virology, vol. 47, no. 2, pp. 201–202, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. T. Lazzarotto, P. Spezzacatena, S. Varani et al., “Anticytomegalovirus (Anti-CMV) immunoglobulin G avidity in identification of pregnant women at risk of transmitting congenital CMV infection,” Clinical and Diagnostic Laboratory Immunology, vol. 6, no. 1, pp. 127–129, 1999. View at Scopus
  11. G. Nigro, S. P. Adler, R. La Torre, and A. M. Best, “Passive immunization during pregnancy for congenital cytomegalovirus infection,” The New England Journal of Medicine, vol. 353, no. 13, pp. 1350–1362, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. C. Vauloup-Fellous, O. Picone, A. G. Cordier et al., “Does hygiene counseling have an impact on the rate of CMV primary infection during pregnancy? Results of a 3-year prospective study in a French hospital,” Journal of Clinical Virology, vol. 46, no. 4, pp. S49–S53, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. S. A. Ross, K. B. Fowler, G. Ashrith et al., “Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity,” Journal of Pediatrics, vol. 148, no. 3, pp. 332–336, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. K. B. Fowler, S. Stagno, and R. F. Pass, “Maternal immunity and prevention of congenital cytomegalovirus infection,” Journal of the American Medical Association, vol. 289, no. 8, pp. 1008–1011, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. R. La Torre, G. Nigro, M. Mazzocco, A. M. Best, and S. P. Adler, “Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease,” Clinical Infectious Diseases, vol. 43, no. 8, pp. 994–1000, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  16. E. Maidji, G. Nigro, T. Tabata et al., “Antibody treatment promotes compensation for human cytomegalovirus-induced pathogenesis and a hypoxia-like condition in placentas with congenital infection,” American Journal of Pathology, vol. 177, no. 3, pp. 1298–1310, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  17. G. Nigro, R. La Torre, H. Pentimalli et al., “Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy,” Prenatal Diagnosis, vol. 28, no. 6, pp. 512–517, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  18. R. L. Naeye, “Cytomegalic inclusion disease. The fetal disorder,” American Journal of Clinical Pathology, vol. 47, no. 6, pp. 738–744, 1967. View at Scopus
  19. S. Stagno and R. J. Whitley, “Herpesvirus infections of pregnancy. Part I: cytomegalovirus and Epstein-Barr virus infections,” The New England Journal of Medicine, vol. 313, no. 20, pp. 1270–1274, 1985.
  20. S. Francisse, P. Revelard, V. De Maertelaer, E. Strebelle, Y. Englert, and C. Liesnard, “Human cytomegalovirus seroprevalence and risk of seroconversion in a fertility clinic population,” Obstetrics and Gynecology, vol. 114, no. 2, pp. 285–291, 2009. View at Publisher · View at Google Scholar · View at PubMed
  21. S. P. Adler, “Cytomegalovirus and child day care: risk factors for maternal infection,” Pediatric Infectious Disease Journal, vol. 10, no. 8, pp. 590–594, 1991.
  22. S. P. Adler, J. W. Finney, A. M. Manganello, and A. M. Best, “Prevention of child-to-mother transmission of cytomegalovirus among pregnant women,” Journal of Pediatrics, vol. 145, no. 4, pp. 485–491, 2004. View at Publisher · View at Google Scholar · View at PubMed
  23. S. P. Adler, J. W. Finney, A. M. Manganello, and A. M. Best, “Prevention of child-to-mother transmission of cytomegalovirus by changing behaviors: a randomized controlled trial,” Pediatric Infectious Disease Journal, vol. 15, no. 3, pp. 240–246, 1996. View at Publisher · View at Google Scholar
  24. S. P. Adler, “Cytomegalovirus and child day care: evidence for an increased infection rate among day-care workers,” The New England Journal of Medicine, vol. 321, no. 19, pp. 1290–1296, 1989.
  25. C. Hutto, R. Ricks, M. Garvie, and R. F. Pass, “Epidemiology of cytomegalovirus infections in young children: day care vs. home care,” Pediatric Infectious Disease, vol. 4, no. 2, pp. 149–152, 1985.
  26. S. P. Adler, “Cytomegalovirus and child day care: evidence for an increased infection rate among day-care workers,” The New England Journal of Medicine, vol. 321, no. 19, pp. 1290–1296, 1989.
  27. R. F. Pass, C. Hutto, R. Ricks, and G. A. Cloud, “Increased rate of CMV infection among parents of children attending day-care centers,” The New England Journal of Medicine, vol. 314, no. 22, pp. 1414–1416, 1986.
  28. K. B. Fowler and R. F. Pass, “Risk factors for congenital cytomegalovirus infection in the offspring of young women: exposure to young children and recent onset of sexual activity,” Pediatrics, vol. 118, no. 2, pp. 286–292, 2006. View at Publisher · View at Google Scholar · View at PubMed
  29. J. R. Murph, J. C. Baron, C. K. Brown, C. L. Ebelhack, and J. F. Bale Jr., “The occupational risk of cytomegalovirus infection among day-care providers,” Journal of the American Medical Association, vol. 265, no. 5, pp. 603–608, 1991. View at Publisher · View at Google Scholar
  30. R. F. Pass, C. Hutto, D. Lyon, and G. Cloud, “Increased rate of cytomegalovirus infection among day care center workers,” Pediatric Infectious Disease Journal, vol. 9, no. 7, pp. 465–470, 1990.
  31. S. P. Adler, “Cytomegalovirus,” in Hospital Epidemiology and Infection Control, G. Mayhall, Ed., Williams & Wilkins, Philadelphia, Pa, USA, 3rd edition, 2004.
  32. S. P. Adler, “Molecular epidemiology of cytomegalovirus: a study of factors affecting transmission among children at three day-care centers,” Pediatric Infectious Disease Journal, vol. 10, no. 8, pp. 584–590, 1991.
  33. B. C. Marshall and S. P. Adler, “The frequency of pregnancy and exposure to cytomegalovirus (CMV) infections among women with a young child in day care,” American Journal of Obstetrics and Gynecology, vol. 200, no. 2, pp. 163–165, 2008. View at Publisher · View at Google Scholar · View at PubMed
  34. K. Lagrou, M. Bodeus, M. Van Ranst, and P. Goubau, “Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays,” Journal of Clinical Microbiology, vol. 47, no. 6, pp. 1695–1699, 2009. View at Publisher · View at Google Scholar · View at PubMed
  35. P. Carlier, N. Harika, R. Bailly, and G. Vranken, “Laboratory evaluation of the new access® cytomegalovirus immunoglobulin IgM and IgG assays,” Journal of Clinical Virology, vol. 49, no. 3, pp. 192–197, 2010. View at Publisher · View at Google Scholar · View at PubMed
  36. M. G. Revello and G. Gerna, “Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant,” Clinical Microbiology Reviews, vol. 15, no. 4, pp. 680–715, 2002. View at Publisher · View at Google Scholar
  37. M. De Paschale, C. Agrappi, M. T. Manco, and P. Clerici, “Positive predictive value of anti-HCMV IgM as an index of primary infection,” Journal of Virological Methods, vol. 168, no. 1-2, pp. 121–125, 2010. View at Publisher · View at Google Scholar · View at PubMed
  38. P. Duff, “A thoughtful algorithm for the accurate diagnosis of primary CMV infection in pregnancy,” American Journal of Obstetrics and Gynecology, vol. 196, no. 3, pp. 196–197, 2007. View at Publisher · View at Google Scholar · View at PubMed
  39. C. Donner, C. Liesnard, J. Content, A. Busine, J. Aderca, and F. Rodesch, “Prenatal diagnosis of 52 pregnancies at risk for congenital cytomegalovirus infection,” Obstetrics and Gynecology, vol. 82, no. 4, pp. 481–486, 1993.
  40. S. Lipitz, S. Yagel, E. Shalev, R. Achiron, S. Mashiach, and E. Schiff, “Prenatal diagnosis of fetal primary cytomegalovirus infection,” Obstetrics & Gynecology, vol. 89, no. 5, pp. 763–767, 1997. View at Publisher · View at Google Scholar
  41. A. Z. Azam, Y. Vial, C. L. Fawer, J. Zuffrey, and P. Hohlfeld, “Prenatal diagnosis of congenital cytomegalovirus infection,” Obstetrics & Gynecology, vol. 97, pp. 443–448, 2001.
  42. S. Gouarin, E. Gault, A. Vabret et al., “Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection,” Journal of Clinical Microbiology, vol. 40, no. 5, pp. 1767–1772, 2002. View at Publisher · View at Google Scholar
  43. T. Goegebuer, B. Van Meensel, K. Beuselinck et al., “Clinical predictive value of real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples,” Journal of Clinical Microbiology, vol. 47, no. 3, pp. 660–665, 2009. View at Publisher · View at Google Scholar · View at PubMed
  44. B. Guerra, G. Simonazzi, C. Puccetti et al., “Ultrasound prediction of symptomatic congenital cytomegalovirus infection,” American Journal of Obstetrics and Gynecology, vol. 198, no. 4, pp. 380.e1–380.e7, 2008. View at Publisher · View at Google Scholar · View at PubMed
  45. G. Benoist, L. J. Salomon, F. Jacquemard, F. Daffos, and Y. Ville, “The prognostic value of ultrasound abnormalities and biological parameters in blood of fetuses infected with cytomegalovirus,” Journal of Obstetrics and Gynaecology, vol. 115, no. 7, pp. 823–829, 2008. View at Publisher · View at Google Scholar · View at PubMed
  46. M. J. Cannon and K. F. Davis, “Washing our hands of the congenital cytomegalovirus disease epidemic,” BMC Public Health, vol. 5, no. 70, 2005. View at Publisher · View at Google Scholar · View at PubMed
  47. B. Anderson, J. Schulkin, D. S. Ross, S. A. Rasmussen, J. L. Jones, and M. J. Cannon, “Kowledge and practices of obstetricians and gynecologists regarding cytomegalovirus infection during pregnancy,” Morbidity and Mortality Weekly Report, vol. 57, no. 3, pp. 65–68, 2008.
  48. American College of Obstetricians and Gynecologists, Perinatal Viral and Parasitic Infections, ACOG Practice Bulletin, American College of Obstetricians and Gynecologists, Washington, DC, USA, 20th edition, 2000.
  49. M. Ballow, “Mechanisms of action of intravenous immune serum globulin therapy,” Pediatric Infectious Disease Journal, vol. 13, no. 9, pp. 806–811, 1994.
  50. A. L. Clark and S. A. Gall, “Clinical uses of intravenous immunoglobulin in pregnancy,” American Journal of Obstetrics and Gynecology, vol. 176, no. 1, pp. 241–253, 1997.
  51. M. A. Keller and E. R. Stiehm, “Passive immunity in prevention and treatment of infectious diseases,” Clinical Microbiology Reviews, vol. 13, no. 4, pp. 602–614, 2000. View at Publisher · View at Google Scholar
  52. A. Porath, R. A. McNutt, L. M. Smiley, and K. A. Weigle, “Effectiveness and cost benefit of a proposed live cytomegalovirus vaccine in the prevention of congenital disease,” Reviews of Infectious Diseases, vol. 12, no. 1, pp. 31–40, 1990.
  53. W. Goodnight, D. Soper, and K. Simpson, “Cost-effectiveness of antenatal maternal CMV serologic screening for reduction of congenital CMV sequelae,” in Proceedings of the 34th Annual Meeting of the Infectious Disease Society for Obstetrics and Gynecology, 2007.
  54. A. G. Cahill, A. O. Odibo, D. M. Stamilio, and G. A. Macones, “Screening and treating for primary cytomegalovirus infection in pregnancy: where do we stand? A decision-analytic and economic analysis,” American Journal of Obstetrics and Gynecology, vol. 201, no. 5, pp. 466.e1–466.e7, 2009. View at Publisher · View at Google Scholar · View at PubMed
  55. Y. Schlesinger, “Routine screening for CMV in pregnancy: opening the pandora box?” Israel Medical Association Journal, vol. 9, no. 5, pp. 395–397, 2007.
  56. Y. Yinon, D. Farine, M. H. Yudin et al., “Cytomegalovirus infection in pregnancy,” Journal of Obstetrics and Gynaecology Canada, vol. 32, no. 4, pp. 348–354, 2010.
  57. P. D. Griffiths, “Progress towards interrupting intrauterine transmission of cytomegalovirus?” Reviews in Medical Virology, vol. 16, no. 1, pp. 1–4, 2006. View at Publisher · View at Google Scholar · View at PubMed
  58. A. G. Biotest, “Interim analysis of the cytotect(R) phase III trial in congenital cytomegalovirus (CMV) infection shows clear indication of efficacy,” http://www.tradesignalonline.com/charts/news.aspx?id=744444&filter=&catid=0.
  59. S. P. Adler, S. E. Starr, S. A. Plotkin et al., “Immunity induced by primary human cytomegalovirus infection protects against secondary infection among women of childbearing age,” Journal of Infectious Diseases, vol. 171, no. 1, pp. 26–32, 1995.
  60. R. F. Pass, C. H. Zhang, A. Evans et al., “Vaccine prevention of maternal cytomegalovirus infection,” The New England Journal of Medicine, vol. 360, no. 12, pp. 1191–1199, 2009. View at Publisher · View at Google Scholar · View at PubMed
  61. B. Guerra, G. Simonazzi, A. Banfi et al., “Impact of diagnostic and confirmatory tests and prenatal counseling on the rate of pregnancy termination among women with positive cytomegalovirus immunoglobulin M antibody titers,” American Journal of Obstetrics and Gynecology, vol. 196, no. 3, pp. 221.e1–221.e6, 2007. View at Publisher · View at Google Scholar · View at PubMed
  62. G. Rahav, R. Gabbay, A. Ornoy, S. Shechtman, J. Arnon, and O. Diav-Citrin, “Primary versus nonprimary cytomegalovirus infection during pregnancy, Israel,” Emerging Infectious Diseases, vol. 13, no. 11, p. 3, 2007.